Kalvista Pharmaceuticals Stock Price on June 20, 2024
| KALV Stock | USD 10.06 0.03 0.30% |
Below is the normalized historical share price chart for Kalvista Pharmaceuticals extending back to April 09, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Kalvista Pharmaceuticals stands at 10.06, as last reported on the 2nd of December, with the highest price reaching 10.21 and the lowest price hitting 9.83 during the day.
If you're considering investing in Kalvista Stock, it is important to understand the factors that can impact its price. Kalvista Pharmaceuticals has Sharpe Ratio of -0.0465, which conveys that the firm had a -0.0465% return per unit of risk over the last 3 months. Kalvista Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kalvista Pharmaceuticals' Standard Deviation of 4.75, risk adjusted performance of (0.03), and Mean Deviation of 3.3 to check out the risk estimate we provide.
At this time, Kalvista Pharmaceuticals' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 247.2 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 18.1 K in 2024. . Price Earnings To Growth Ratio is likely to climb to 0.59 in 2024, whereas Price To Sales Ratio is likely to drop 46.33 in 2024. Kalvista Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of April 2015 | 200 Day MA 12.0228 | 50 Day MA 10.9631 | Beta 0.913 |
Kalvista |
Sharpe Ratio = -0.0465
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KALV |
Estimated Market Risk
| 4.72 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Kalvista Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kalvista Pharmaceuticals by adding Kalvista Pharmaceuticals to a well-diversified portfolio.
Price Book 2.8652 | Enterprise Value Ebitda (3.53) | Price Sales 107.4168 | Shares Float 24.9 M | Wall Street Target Price 29.1667 |
Related Headline
Larimar Therapeutics Headline on 20th of June 2024
Acquisition by Flynn James E of 16600 shares of Larimar Ther... by Flynn James E
Filed transaction by Larimar Therapeutics Director, 10 Percent Owner . Grant, award or other acquisition pursuant to Rule 16b-3
Kalvista Pharmaceuticals Valuation on June 20, 2024
It is possible to determine the worth of Kalvista Pharmaceuticals on a given historical date. On June 20, 2024 Kalvista was worth 11.33 at the beginning of the trading date compared to the closed value of 11.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Kalvista Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Kalvista Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kalvista Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Kalvista Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 11.77 | 11.82 | 11.28 | 11.37 | 226,976 | |
06/20/2024 | 11.33 | 11.35 | 11.07 | 11.21 | 161,857 |
| 11.32 | 11.78 | 11.32 | 11.74 | 936,250 |
| Backtest Kalvista Pharmaceuticals | | | Kalvista Pharmaceuticals History | | | Kalvista Pharmaceuticals Valuation | Previous | Next |
Kalvista Pharmaceuticals Trading Date Momentum on June 20, 2024
| On June 21 2024 Kalvista Pharmaceuticals was traded for 11.74 at the closing time. The top price for the day was 11.78 and the lowest listed price was 11.32 . The trading volume for the day was 936.2 K. The trading history from June 21, 2024 was a factor to the next trading day price increase. The trading delta at closing time against the next closing price was 4.73% . The trading delta at closing time against the current closing price is 4.01% . |
Kalvista Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Kalvista Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Kalvista financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Kalvista Pharmaceuticals Stock history
Kalvista Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kalvista is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kalvista Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kalvista Pharmaceuticals stock prices may prove useful in developing a viable investing in Kalvista Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 36.8 M | 38.6 M | |
| Net Loss | -24.8 M | -26.1 M |
Kalvista Pharmaceuticals Quarterly Net Working Capital |
|
Kalvista Pharmaceuticals Stock Technical Analysis
Kalvista Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Kalvista Pharmaceuticals Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Kalvista Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Kalvista Pharmaceuticals December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Kalvista Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kalvista Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Kalvista Pharmaceuticals stock market strength indicators, traders can identify Kalvista Pharmaceuticals entry and exit signals to maximize returns
Kalvista Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kalvista Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Kalvista Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kalvista to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (1.07) | |||
| Treynor Ratio | (0.14) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.